Albumedix

Lyngby, Denmark Founded: 2016 • Age: 10 yrs Acquired By Sartorius
Albumin-based products and technologies for biotherapeutics development are provided.
Request Access

About Albumedix

Albumedix is a company based in Lyngby (Denmark) founded in 2016 was acquired by Sartorius in August 2022.. The company has 106 employees as of December 31, 2021.

  • Headquarter Lyngby, Denmark
  • Employees 106 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Albumedix Ltd
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $38.24 M (USD)
    21
    as on Dec 31, 2021
  • Net Profit
    $6.61 M (USD)
    -2
    as on Dec 31, 2021
  • EBITDA
    $7.78 M (USD)
    -2
    as on Dec 31, 2021
  • Latest Funding Round
    $335.35 K (USD), Grant

    Sep 01, 2020

  • Investors
    Sartorius

    & 1 more

  • Employee Count
    106

    as on Dec 31, 2021

  • Acquired by
    Sartorius

    (Aug 09, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Albumedix

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $335,353
  • First Round

    (01 Sep 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2020 Amount Grant - Albumedix Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Albumedix

Albumedix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Sartorius and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Laboratory and biopharmaceutical equipment is developed for production processes.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Albumedix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Albumedix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Albumedix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Albumedix

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Albumedix

Frequently Asked Questions about Albumedix

When was Albumedix founded?

Albumedix was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Where is Albumedix located?

Albumedix is headquartered in Lyngby, Denmark. It is registered at Lyngby, Region Hovedstaden, Denmark.

How many employees does Albumedix have?

As of Dec 31, 2021, the latest employee count at Albumedix is 106.

What is the annual revenue of Albumedix?

Annual revenue of Albumedix is $38.24M as on Dec 31, 2021.

What does Albumedix do?

Albumedix was spun-out as a fully owned subsidiary from the Biopharma activities of Novozymes. Albumedix helps biopharmaceutical companies improve patient outcomes with a range of albumin-based products and technologies that facilitate the development of biotherapeutics. Named Recombumin, Albumedixs recombinant albumins are used in the pharmaceutical industry to stabilize drugs and vaccines, extend drug half-life and improve drug delivery (Albumedix offers a first and second generation version of this drug delivery technology under the name Veltis). Their products and technologies are used in clinical and marketed drugs and out-licensed to pharmaceutical and biotech companies. They also use this expertise to strengthen our own drug pipeline. since 2006, Merck has used Albumedixs solutions to produce two vaccines used to treat millions of children worldwide against measles, mumps, rubella and chicken pox. In 2014, Veltis got its commercial breakthrough when GlaxoSmithKline launched a diabetes drug that utilizes the technology, allowing patients to dose weekly instead of daily. In Jan 2016, Albumedix acquired Eleven Therapeutics proprietary Supermin albumin variant assets.

Who are Albumedix's investors?

Albumedix has 2 investors. Key investors include Sartorius, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available